Dicerna Pharmaceuticals, Inc.(DRNA)- NASDAQ
From other sites
Company Description
Dicerna Pharmaceuticals, Inc. engages in the discovery, research, and development of treatments based on RNAi technology platform. It uses its proprietary RNA interference technology platform, which it believes improves on existing RNAi technologies, to build a broad pipeline in these... More
Sector: Healthcare
Industry: Biotechnology
Country: United States